Aplastic crisis: Difference between revisions

(new page, new sections, hyperlinks, citations)
 
No edit summary
 
(7 intermediate revisions by 4 users not shown)
Line 3: Line 3:
*Clinically common in [[Sickle cell crisis]] and [[Hereditary Spherocytosis (HS)]]
*Clinically common in [[Sickle cell crisis]] and [[Hereditary Spherocytosis (HS)]]


==Clinical Presentation==
==Clinical Features==
*[[Sickle cell crisis]]
*[[Sickle cell crisis]]
*[[Anemia]]
*[[Anemia]]
*Increased fatigue, pallor
*Increased [[fatigue]], pallor
*Activity intolerance
*Activity intolerance
*Shortness of breath
*[[Shortness of breath]]


==Causes==
==Causes==
*[[Erythema Infectiosum (Fifth disease)]]
*[[Erythema Infectiosum (Fifth disease)]]
**Invades and destroys red blood cell precursors and halts the red cell production
**Invades and destroys red blood cell precursors and halts the red cell production
*EBV
*[[EBV]]
*Strep infection
*[[Strep]] infection
*Use of hydroxyurea
*Use of [[hydroxyurea]]


==Labs==
==Labs==
*CBC w/ retic count
*CBC with retic count
**Decrease from baseline H/H
**[[anemia|Decrease from baseline hemoglobin/hematocrit]]
**Precipitous drop in reticulocyte count (or lack of response)
**Precipitous drop in reticulocyte count (or lack of response)


==Management==
==Management==
*Admit
*[[pRBCs|Transfusion]] using extended antigen-typed, leuko-depleted pRBCs
*Transfusion using extended antigen-typed, leuko-depleted pRBCs
*Droplet precautions


==Recovery Phase==
==Recovery Phase==
*Typically in 1-2 weeks
*Typically in 1-2 weeks
*Often marked by hyperbilirubinemia, and called a “hyperhemolytic” phase<ref>http://www.ihtc.org/medical-professionals/blood-disorders/sickle-cell-disease/aplastic-crisis-intervention/</ref>
*Often marked by hyperbilirubinemia, and called a “hyperhemolytic” phase<ref>http://www.ihtc.org/medical-professionals/blood-disorders/sickle-cell-disease/aplastic-crisis-intervention/</ref>
==Disposition==
*Admit


==Also See==
==Also See==
Line 35: Line 38:
*[[Sickle cell crisis]]
*[[Sickle cell crisis]]


==Source==
==References==
<references/>
*Janz TJ, Hamilton GC: Anemia, Polycythemia, and White Blood Cell Disorders, in Marx JA, Hockberger RS, Walls RM, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 7. St. Louis, Mosby, Inc., 2010, (Ch) 119:p 1568-1574.
*Janz TJ, Hamilton GC: Anemia, Polycythemia, and White Blood Cell Disorders, in Marx JA, Hockberger RS, Walls RM, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 7. St. Louis, Mosby, Inc., 2010, (Ch) 119:p 1568-1574.
*http://www.ihtc.org/medical-professionals/blood-disorders/sickle-cell-disease/aplastic-crisis-intervention/ - last accessed 1/6/15
*http://www.ihtc.org/medical-professionals/blood-disorders/sickle-cell-disease/aplastic-crisis-intervention/ - last accessed 1/6/15

Latest revision as of 23:40, 30 September 2019

Background

Clinical Features

Causes

Labs

Management

  • Transfusion using extended antigen-typed, leuko-depleted pRBCs
  • Droplet precautions

Recovery Phase

  • Typically in 1-2 weeks
  • Often marked by hyperbilirubinemia, and called a “hyperhemolytic” phase[1]

Disposition

  • Admit

Also See

References